News
Important research collaboration for pioneering PRS approach
Oxford & Manchester, UK. Cytox, a precision medicine front-runner which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developi...
Manchester - 8th May 2018. An innovative solution designed to identify infection in dialysis patients has completed a successful pilot clinical investigation following a funding award from Health Innovation Manchester.
Manchester-based medi...
Pioneering PRS approach verified for banked DNA, blood and saliva samples
OXFORD, England & MANCHESTER, England & ATLANTA--(BUSINESS WIRE)--Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other...
Alderley Park, UK, 26 March 2018 – Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage investment from the GM&C Life Sciences Fun...
Manchester UK, 21st March 2018 - Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures.
Renephra, spun out of The Unive...